[{"id":"00b2a65e-e9e4-4df1-bdcb-e920bada9c34","acronym":"","url":"https://clinicaltrials.gov/study/NCT05941156","created_at":"2023-07-12T16:10:08.845Z","updated_at":"2024-07-02T16:35:43.307Z","phase":"Phase 2","brief_title":"Clinical Study of Anti-CD56-CAR-T in the Treatment of Relapsed/Refractory NK/T Cell Lymphoma /NK Cell Leukemia","source_id_and_acronym":"NCT05941156","lead_sponsor":"The Affiliated Hospital of Xuzhou Medical University","biomarkers":" IL6 • NCAM1 • IL10 • IL4","pipe":"","alterations":" ","tags":["IL6 • NCAM1 • IL10 • IL4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • anti-CD56-CAR-T"],"overall_status":"Recruiting","enrollment":" Enrollment 20","initiation":"Initiation: 05/01/2023","start_date":" 05/01/2023","primary_txt":" Primary completion: 05/01/2026","primary_completion_date":" 05/01/2026","study_txt":" Completion: 05/01/2026","study_completion_date":" 05/01/2026","last_update_posted":"2023-07-12"}]